1 Introduction
==============

Untargeted metabolite profiling is a promising approach to discover novel risk factors for chronic diseases and biomarkers for disease diagnosis ([@btu705-B8]; [@btu705-B5]). Liquid chromatography coupled to high-resolution mass spectrometry (LC--hrMS) instrumentation is being more routinely used for data-acquisition for metabolomic analyses in large-scale studies (e.g. \>300 samples). Raw data need to be processed via computational tools to extract relevant information and meaningful biological conclusions.

Processing of LC--hrMS raw data is currently facilitated by softwares such as XCMS, MzMine, MetaboAnalyst and Maven ([@btu705-B6]; [@btu705-B4]; [@btu705-B1]; [@btu705-B9]). However, an automated software pipeline with minimal manual interaction for efficient, reproducible and objective large-scale metabolomic data analysis is also desirable. Software tools can systematically perform all downstream aspects of metabolomic analysis following peak-picking. Development of such a workflow in the R language can offer several advantages such as availability of modular packages for functional programming and graphics and the ease of accessibility of a GUI for non-specialists.

We have developed novel software, MetMSLine, coded in the R language which automates the process of untargeted metabolomic data analyses of large datasets from acquisition of data from LC--hrMS platforms through to unknown biomarker identification.

2 Results
=========

An overview of data processing steps that are integrated by MetMSLine is shown in [Figure 1](#btu705-F1){ref-type="fig"}. Use of the software via GUI requires a clear understanding of data processing steps in metabolomics. Fig. 1.Data acquisition and MetMSLine data processing workflow (Steps 1--4). Sample preparation (e.g. urine dilution) is followed by untargeted MS and MS/MS data acquisition in sequence and peak picking softwares MetMSLine then performs sequentially: signal drift correction and pre-processing (Step 1), automatic PCA-based outlier removal (Step 2) (samples = black, QCs = red, outliers = green), automatic iterative regression based on continuous *Y*-variables supplied and cluster ion identification (Step 3) and final identification by data-dependent MS/MS and database matching (Step 4)

2.1 Step 1: Pre-processing of raw data matrix from XCMS
-------------------------------------------------------

Large LC--hrMS metabolomics datasets contain unwanted variation introduced by MS signal drift/attenuation and multiplicative noise across the dynamic range. These effects can detrimentally impact biomarker discovery and MS features require rigorous quality assurance. *PreProc.QC.LSC* first zero-fills data, then if sample normalization is required the median fold change method can also be applied ([@btu705-B7]). *PreProc.QC.LSC* then uses the QC-based locally weighted scatter-plot smoothing method to alleviate the effects of signal drift ([@btu705-B3]). The degree of smoothing is controlled by the smoother span value (e.g. *f* = 1/5), this argument sets the proportion of points used to smooth at each point. Data are then Log-transformed and finally features analytically stable across the regularly injected (every 5--10 true sample) pooled QCs are retained (e.g. RSD = 30, i.e. \<30% relative standard deviation).

2.2 Step 2: Removal of outliers
-------------------------------

The next function performs automated removal of outliers in the pre-processed data based on expansion of the Hotellings T2 distribution ellipse. The argument 'out.tol' (outlier tolerance) controls the proportional expansion of the ellipse (e.g. 1.1 or a 10% proportional expansion). Any samples within the first and second component PCA score plot beyond this expanded ellipse are removed and the PCA model recalculated. Assuming outliers are detected *Auto.PCA* performs two rounds of outlier removal and saves details of outliers removed along with corresponding samples from the *Y-*variable data table supplied in the parent directory in .csv format.

2.3 Step 3: Multivariate regression
-----------------------------------

*Auto.MV.Regress* utilizes continuous *Y-*variables to regress to the pre-processed MS dataset. *Auto.MV.Regress* creates a subfolder for each *Y*-variable supplied, then identifies potential biomarkers based on a user-defined correlation threshold (e.g. Corr.thresh = 0.3) and below a multiple testing corrected *P*-value (*P* = 0.01) and both scatterplots and box and whisker plots are generated. Potential biomarkers above the threshold are hierarchically clustered and '*X*--*Y*' and '*X*--*X*' heatmaps generated. Inter-feature clustering (*X--X*) is used to identify cluster ions from a list of 88 isotope, adduct, fragment and co-metabolite mass shifts.

2.4 Step 4 (i): MS/MS matching for biomarker structure elucidation
------------------------------------------------------------------

As an LC--hrMS platform can acquire MS/MS data with precise masses, we coded a function to use the MS/MS data for the identification of metabolites. This function matches potential biomarkers identified by *Auto.MV.Regress* to MS/MS fragmentation spectra by a retention time window (ret = 10 s) and mass tolerance (Frag.ppm = 20). *Auto.MS.MS.match* calculates the precursor (in blue on plot) to fragment (in red on plot) and inter-fragment mass differences, and labels where available the neutral losses/fragments commonly encountered in MS/MS spectra.

2.5 Step 4 (ii): Compound annotation using exact mass matching
--------------------------------------------------------------

The final function utilizes targeted lists of experiment-specific anticipated metabolites (in .csv format) provided by the user to annotate the unknown biomarkers. *DBAnnotate* optionally calculates from the targeted lists of anticipated metabolites, expected *m*/*z* of both typical phase II conjugates and electrospray adducts. *DBAnnotate* matches against all iterations of these potential theoretical masses below user-defined mass tolerances (MassAcc = 10 ppm) and returns an aggregated result table.

3 Conclusion
============

MetMSLine presents a complete data processing method; it is easy to use as a GUI and should be very beneficial to researchers to rapidly process large-scale LC--hrMS dataset. It potentially requires minimal manual interaction with the software, when compared with the high-manual interaction required by commonly used softwares for LC--hrMS datasets such as MetaboAnalyst, MAVEN, apLCMS, MzMine and IDEOM ([@btu705-B10]; [@btu705-B4]; [@btu705-B1]; [@btu705-B2]; [@btu705-B9]). The rapidity of the process allows great scope for parameter optimization and the subsequent ability to dedicate more time to result interpretation.
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